Details for New Drug Application (NDA): 021306
✉ Email this page to a colleague
The generic ingredient in BUTRANS is buprenorphine. There are twenty-nine drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the buprenorphine profile page.
Summary for 021306
| Tradename: | BUTRANS |
| Applicant: | Purdue Pharma Lp |
| Ingredient: | buprenorphine |
| Patents: | 0 |
Pharmacology for NDA: 021306
| Mechanism of Action | Partial Opioid Agonists |
Medical Subject Heading (MeSH) Categories for 021306
Suppliers and Packaging for NDA: 021306
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| BUTRANS | buprenorphine | FILM, EXTENDED RELEASE;TRANSDERMAL | 021306 | NDA AUTHORIZED GENERIC | Rhodes Pharmaceuticals L.P. | 42858-353 | 42858-353-40 | 4 POUCH in 1 CARTON (42858-353-40) / 1 PATCH in 1 POUCH / 168 h in 1 PATCH |
| BUTRANS | buprenorphine | FILM, EXTENDED RELEASE;TRANSDERMAL | 021306 | NDA AUTHORIZED GENERIC | Rhodes Pharmaceuticals L.P. | 42858-493 | 42858-493-40 | 4 POUCH in 1 CARTON (42858-493-40) / 1 PATCH in 1 POUCH / 168 h in 1 PATCH |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | FILM, EXTENDED RELEASE;TRANSDERMAL | Strength | 5MCG/HR | ||||
| Approval Date: | Jun 30, 2010 | TE: | AB | RLD: | Yes | ||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | RX | Dosage: | FILM, EXTENDED RELEASE;TRANSDERMAL | Strength | 10MCG/HR | ||||
| Approval Date: | Jun 30, 2010 | TE: | AB | RLD: | Yes | ||||
Profile for product number 003
| Active Rx/OTC/Discontinued: | RX | Dosage: | FILM, EXTENDED RELEASE;TRANSDERMAL | Strength | 20MCG/HR | ||||
| Approval Date: | Jun 30, 2010 | TE: | AB | RLD: | Yes | ||||
Expired US Patents for NDA 021306
Complete Access Available with Subscription
